Showing results (4091-4100 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 23, 2012
Resolving differences in substrate specificities between human and parasite phosphoribosyltransferases via analysis of functional groups of substrates and receptorsZofia Gasik, David Shugar, Jan M AntosiewiczCurrent Pharmaceutical Design|November 23, 2012
Protein: ligand recognition: simple models for electrostatic effectsThomas SimonsonCurrent Pharmaceutical Design|June 12, 2012
Sleep and antidepressant treatmentAdam Wichniak, Aleksandra Wierzbicka, Wojciech JernajczykCurrent Pharmaceutical Design|June 12, 2012
The role of oxidative stress in depressive disordersTanja Maria Michel, Dietrich Pülschen, Johannes ThomeCurrent Pharmaceutical Design|June 12, 2012
Glucose metabolism and antidepressant medicationJohannes M Hennings, Ludwig Schaaf, Stephany FuldaCurrent Pharmaceutical Design|June 12, 2012
Inflammatory cytokines, growth factors, and depressionFrancis LotrichCurrent Pharmaceutical Design|November 5, 2013
Pharmacology and clinical pharmacology of methylarginines used as inhibitors of nitric oxide synthasesAnja Kittel, Renke MaasCurrent Pharmaceutical Design|November 5, 2013
Pharmacological prevention of eNOS uncouplingHuige Li, Ulrich ForstermannCurrent Pharmaceutical Design|November 5, 2013
Regulation of eNOS enzyme activity by posttranslational modificationElke H Heiss, Verena M DirschCurrent Pharmaceutical Design|November 5, 2013
Neurogenesis as a new target for the development of antidepressant drugsJesus Pascual-Brazo, Veerle Baekelandt, Juan Manuel EncinasPageof 1,008